Form 8-K - Current report:
SEC Accession No. 0000950103-26-011876
Filing Date
2026-08-04
Accepted
2026-08-04 16:05:36
Documents
13
Period of Report
2026-08-04
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp251262_8k.htm   iXBRL 8-K 21430
2 EXHIBIT 99.1 dp251262_ex9901.htm EX-99.1 77139
6 GRAPHIC image_001.jpg GRAPHIC 1795
  Complete submission text file 0000950103-26-011876.txt   275831

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pgen-20260804.xsd EX-101.SCH 3014
4 XBRL LABEL FILE pgen-20260804_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE pgen-20260804_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT dp251262_8k_htm.xml XML 3079
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 261238544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)